Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EPS (Weighted Average and Diluted) (2016 - 2026)

Healthequity has reported EPS (Weighted Average and Diluted) over the past 14 years, most recently at $0.58 for Q1 2026.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.58 for Q1 2026, up 93.33% from a year ago — trailing twelve months through Jan 2026 was $2.46 (up 125.69% YoY), and the annual figure for FY2026 was $2.46, up 125.69%.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.58 at Healthequity, down from $0.59 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for HQY hit a ceiling of $0.68 in Q3 2025 and a floor of -$0.39 in Q1 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.17 (2023), compared with a mean of $0.21.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 657.14% in 2022 and later surged 12220.86% in 2024.
  • Healthequity's EPS (Weighted Average and Diluted) stood at -$0.02 in 2022, then soared by 950.0% to $0.17 in 2023, then tumbled by 64.71% to $0.06 in 2024, then surged by 883.33% to $0.59 in 2025, then fell by 1.69% to $0.58 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.58 (Q1 2026), $0.59 (Q4 2025), and $0.68 (Q3 2025) per Business Quant data.